findmyKOL
Clinical trialNCT06430411Not, yet, recruitingObservational

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

SponsorMedical University of ViennaEnrollment500OligometastasisOligometastatic DiseaseProstate CancerProstate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Neoplasm
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Abiraterone →Androgen deprivation treatment →Apalutamide →Darolutamide →Docetaxel →Enzalutamide →Lutetium-PSMA →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2024
Primary completion
1 Jan 2031
Completion
31 Dec 2031
Last update posted
28 May 2024
Registered enrollment
500
Registry id
NCT06430411
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.